Brought to you by the IPIC Young Practitioners Committee

In patent litigation today, experiments to prove or disprove the likelihood of infringement are common place. What has remained unclear is whether or not parties have the right to attend such experiments to being performed by the other side(s) to be relied upon at trial, to observe what is being done.

Recently, the Federal Court issued a Notice to the Profession re: Experimental Testing, and its potential impact on patent litigation. In this webinar, members of the Federal Court IP User’s Group Committee will discuss the Notice, given two recent conflicting decisions of the Court prior to its issuance: AbbVie Corp. v. Janssen Inc. (2014 FC 55), and Dow v. Nova (2012 FC 754). Focus will be placed on how practitioners should interpret the language of the Notice, and what it actually means for attendance by opposing parties at experiments intended to be relied upon at trial and the role of their expert witnesses.

Donald Cameron Bereskin & Parr LLP
Jason Markwell Norton Rose Fulbright Canada LLP

Amrita V. Singh Bereskin & Parr LLP

Registration Fees

1-2 people: $149
3 or more people: $299

Non Member
1-2 people: $169
3 or more people: $349





Participants will view the webinar’s presentation online and hear the presenters by phone or through the computer.  A web link and audio coordinates will be provided to the registrant the day before the webinar.

Group Participation

Group participation is possible provided that only one phone line is used to join the audio. Therefore, you may not register a group if participants are in separate locations.

Continuing Professional Development

This program is eligible for up to 1 Substantive Hour.


1 hr


Law Society of Upper Canada



Barreau du Québec



Law Society of British Columbia



Law Society of Saskatchewan



Law Society of Manitoba



Law Society of Alberta



New York CLE Board